|
ZNF615 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.052800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.049600E-02 |
| Normal-vs-Stage2 |
7.550600E-01 |
| Normal-vs-Stage3 |
7.687600E-02 |
| Normal-vs-Stage4 |
2.860600E-03 |
| Stage1-vs-Stage2 |
1.533790E-01 |
| Stage1-vs-Stage3 |
8.018700E-04 |
| Stage1-vs-Stage4 |
1.63494999999569E-05 |
| Stage2-vs-Stage3 |
3.891600E-01 |
| Stage2-vs-Stage4 |
7.841700E-02 |
| Stage3-vs-Stage4 |
2.354200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.386000E-01 |
| Normal-vs-AfricanAmerican |
7.052400E-01 |
| Normal-vs-Asian |
5.451000E-01 |
| Caucasian-vs-AfricanAmerican |
7.239400E-01 |
| Caucasian-vs-Asian |
5.939400E-01 |
| AfricanAmerican-vs-Asian |
5.965200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.407000E-01 |
| Normal-vs-Female |
4.974800E-01 |
| Male-vs-Female |
2.262000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.729600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.806600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.338600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.624200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.445600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.721600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.847600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.734600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.644200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.051600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.308500E-02 |
| Normal-vs-Grade 2 |
2.460200E-03 |
| Normal-vs-Grade 3 |
1.304380E-02 |
| Normal-vs-Grade 4 |
1.64602999999097E-05 |
| Grade 1-vs-Grade 2 |
2.042400E-01 |
| Grade 1-vs-Grade 3 |
3.287500E-02 |
| Grade 1-vs-Grade 4 |
7.238200E-03 |
| Grade 2-vs-Grade 3 |
1.40699999984228E-07 |
| Grade 2-vs-Grade 4 |
3.62259999775461E-10 |
| Grade 3-vs-Grade 4 |
2.384600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.522720E-03 |
| Normal-vs-ccB subtype |
2.490200E-01 |
| ccA subtype-vs-ccB subtype |
4.203800E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.013000E-01 |
| Normal-vs-N1 |
4.377000E-03 |
| N0-vs-N1 |
1.835920E-02 |
|
|
